IL33 and neoplasm: Down regulation of PCAT-1 can induce T cell recruitment and activate IL-13/IL-33 mediated pathway, inhibit tumor metastasis caused by CAF mediated activation of stromal fibroblasts, enhance the sensitivity of tumor cells to chemotherapy drugs and affect the microenvironment of tumor immune cells.